Neumora Therapeutics Inc. Common Stock Analysis
| Analyst Ratings |
|
Average Target Price
|
20.83
|
|
Average Rating
|
4.44
|
|
# Strong Buys
|
5
|
|
# Buys
|
3
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.38
|
-0.45
|
-0.07
|
-18.33%
|
|
2024-06-30
|
-0.36
|
-0.37
|
-0.01
|
-3.47%
|
|
2024-03-31
|
-0.34
|
-0.34
|
0.00
|
0.00%
|
|
2023-12-31
|
-0.55
|
-0.71
|
-0.16
|
-29.09%
|
|
2023-09-30
|
-0.36
|
-1.14
|
-0.78
|
-216.67%
|
|
2023-06-30
|
0.00
|
-0.28
|
-0.28
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-1.16
|
|
2023-12-31
|
-2.13
|